Care Planning Framework in Advanced Bladder Cancer (ABC123)

  • End date
    Dec 14, 2026
  • participants needed
  • sponsor
    University of Colorado, Denver
Updated on 14 June 2022
bladder tumor


Pilot study assessing the feasibility and acceptability of the ABC123 framework, as well as goal concordance between patient and clinician stated goals. Patients >60 years old with recently diagnosed advanced, incurable bladder cancer making an initial treatment decision will be enrolled. The team will pilot test the ABC123 framework delivery by an advanced practice provider working with a medical oncologist to inform the overall care planning process. This framework will routinely incorporate and implement existing resources from these 3 transdisciplinary tenets (geriatric, oncology, palliative medicine) into initial care planning in a patient-centered manner. The team will follow patients from initial care planning to 6 months post intervention and assess additional stakeholder feedback on barriers and facilitators to implementation.


The ABC123 care planning framework is aimed at increasing care alignment delivered to older patients with advance bladder cancer by combining existing tools that represent the principles of geriatrics, oncology, and palliative care. In this pilot study, our primary goals are to assess the feasibility and acceptability of the ABC123 care planning framework and evaluate the framework's impact on the provision of care that aligns with the goals and values of patients. Participants will participate in a series of visits and follow-ups meant to implement and evaluate the ABC123 care planning framework that will take place over the course of six months. The first two visits will consist of 1) a short physical performance battery (SPPB) and estimation of potential for grade 3 chemotherapy toxicity using the Cancer and Aging Research Group chemotherapy toxicity calculator and 2) a guided goals of care discussion with an Advanced Practice Provider based on the findings from visit 1. During 1, 3, and 6 month follow-up sessions, participants will complete a survey consisting of several commonly used questionnaires and an interview about experiences and goals. Care providers and institutional stakeholders will also be interviewed at 1, 2, and 3 years after initial implementation to understand experiences and assess feasibility if the ABC123 framework.

Condition Bladder Cancer
Treatment ABC123 Framework
Clinical Study IdentifierNCT05408507
SponsorUniversity of Colorado, Denver
Last Modified on14 June 2022


Yes No Not Sure

Inclusion Criteria

Provision to sign and date the consent form
Age >65 years old, or >60 with at least one deficit on a geriatric screen
Stated willingness to comply with all study procedures and be available for the duration of the study
Diagnosis of urothelial carcinoma that is not curable with surgery or radiation within the 6 mos. prior to consenting
English speaking only for the pilot portion

Exclusion Criteria

Have Initiated any systemic treatment for advanced urothelial carcinoma
Have a diagnosis of another advanced cancer that has required systemic therapy
Have any condition that, in the opinion of the investigator, would compromise the well- being of the subject or the study or prevent the subject from meeting or performing study requirements
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note